Literature DB >> 33753801

Capsular polysaccharide switching in Streptococcus suis modulates host cell interactions and virulence.

Masatoshi Okura1, Jean-Philippe Auger2, Tomoyuki Shibahara3,4, Guillaume Goyette-Desjardins2, Marie-Rose Van Calsteren5, Fumito Maruyama6,7, Mikihiko Kawai8, Makoto Osaki9, Mariela Segura10, Marcelo Gottschalk11, Daisuke Takamatsu9,12.   

Abstract

The capsular polysaccharide (CPS) of Streptococcus suis defines various serotypes based on its composition and structure. Though serotype switching has been suggested to occur between S. suis strains, its impact on pathogenicity and virulence remains unknown. Herein, we experimentally generated S. suis serotype-switched mutants from a serotype 2 strain that express the serotype 3, 4, 7, 8, 9, or 14 CPS. The effects of serotype switching were then investigated with regards to classical properties conferred by presence of the serotype 2 CPS, including adhesion to/invasion of epithelial cells, resistance to phagocytosis by macrophages, killing by whole blood, dendritic cell-derived pro-inflammatory mediator production and virulence using mouse and porcine infection models. Results demonstrated that these properties on host cell interactions were differentially modulated depending on the switched serotypes, although some different mutations other than loci of CPS-related genes were found in each the serotype-switched mutant. Among the serotype-switched mutants, the mutant expressing the serotype 8 CPS was hyper-virulent, whereas mutants expressing the serotype 3 or 4 CPSs had reduced virulence. By contrast, switching to serotype 7, 9, or 14 CPSs had little to no effect. These findings suggest that serotype switching can drastically alter S. suis virulence and host cell interactions.

Entities:  

Year:  2021        PMID: 33753801      PMCID: PMC7985379          DOI: 10.1038/s41598-021-85882-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  49 in total

Review 1.  Streptococcus suis: a new emerging or an old neglected zoonotic pathogen?

Authors:  Marcelo Gottschalk; Jianguo Xu; Cynthia Calzas; Mariela Segura
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

2.  Genetic analysis of capsular polysaccharide synthesis gene clusters from all serotypes of Streptococcus suis: potential mechanisms for generation of capsular variation.

Authors:  Masatoshi Okura; Daisuke Takamatsu; Fumito Maruyama; Takashi Nozawa; Ichiro Nakagawa; Makoto Osaki; Tsutomu Sekizaki; Marcelo Gottschalk; Yumi Kumagai; Shigeyuki Hamada
Journal:  Appl Environ Microbiol       Date:  2013-02-15       Impact factor: 4.792

3.  Structure determination of Streptococcus suis serotype 14 capsular polysaccharide.

Authors:  Marie-Rose Van Calsteren; Fleur Gagnon; Cynthia Calzas; Guillaume Goyette-Desjardins; Masatoshi Okura; Daisuke Takamatsu; Marcelo Gottschalk; Mariela Segura
Journal:  Biochem Cell Biol       Date:  2012-12-03       Impact factor: 3.626

4.  The C-type lectin CD209b is expressed on microglia and it mediates the uptake of capsular polysaccharides of Streptococcus pneumoniae.

Authors:  Jin-Yeon Park; Heong-Jwa Choi; Miglena G V Prabagar; Woo-Sung Choi; Sun-Jong Kim; Cheolho Cheong; Chae Gyu Park; Chan Young Chin; Young-Sun Kang
Journal:  Neurosci Lett       Date:  2008-12-10       Impact factor: 3.046

5.  Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival.

Authors:  Marjolein Meijerink; Maria Laura Ferrando; Geraldine Lammers; Nico Taverne; Hilde E Smith; Jerry M Wells
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  The C-type lectin receptor Mincle binds to Streptococcus pneumoniae but plays a limited role in the anti-pneumococcal innate immune response.

Authors:  Anne Rabes; Stephanie Zimmermann; Katrin Reppe; Roland Lang; Peter H Seeberger; Norbert Suttorp; Martin Witzenrath; Bernd Lepenies; Bastian Opitz
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

7.  Genotyping and investigating capsular polysaccharide synthesis gene loci of non-serotypeable Streptococcus suis isolated from diseased pigs in Canada.

Authors:  Han Zheng; Xiaotong Qiu; David Roy; Mariela Segura; Pengchen Du; Jianguo Xu; Marcelo Gottschalk
Journal:  Vet Res       Date:  2017-02-20       Impact factor: 3.683

8.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

9.  Control of competence for DNA transformation in streptococcus suis by genetically transferable pherotypes.

Authors:  Edoardo Zaccaria; Peter van Baarlen; Astrid de Greeff; Donald A Morrison; Hilde Smith; Jerry M Wells
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

Review 10.  Current Taxonomical Situation of Streptococcus suis.

Authors:  Masatoshi Okura; Makoto Osaki; Ryohei Nomoto; Sakura Arai; Ro Osawa; Tsutomu Sekizaki; Daisuke Takamatsu
Journal:  Pathogens       Date:  2016-06-24
View more
  3 in total

1.  Synthesis and Application of Rare Deoxy Amino l-Sugar Analogues to Probe Glycans in Pathogenic Bacteria.

Authors:  Phuong Luong; Antara Ghosh; Karen D Moulton; Suvarn S Kulkarni; Danielle H Dube
Journal:  ACS Infect Dis       Date:  2022-03-18       Impact factor: 5.578

2.  Distribution and characterization of Streptococcus suis serotypes isolated from January 2015 to June 2020 from diseased pigs in Québec, Canada.

Authors:  Sonia Lacouture; Yaindrys Rodriguez Olivera; Segura Mariela; Marcelo Gottschalk
Journal:  Can J Vet Res       Date:  2022-01       Impact factor: 0.897

3.  Identification of Streptococcus suis putative zoonotic virulence factors: A systematic review and genomic meta-analysis.

Authors:  Thomas J Roodsant; Boas C L Van Der Putten; Sara M Tamminga; Constance Schultsz; Kees C H Van Der Ark
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.